Towards Healthcare
Human Microbiome Market
Updated Date: 27 November 2025   |   Report Code: 6042
sales@towardshealthcare.com +1 804-441-9344
Download Sample Order Now

Human Microbiome Market Fueled by Modern Healthcare Needs

Market insights predict the global human microbiome industry will increase from USD 1.23 billion in 2025 to USD 18.27 billion by 2035, achieving a CAGR of 30.97%. The market is growing due to rising research on the role of gut health in chronic diseases and increasing demand for microbiome-based therapeutics. Additionally, advancements in sequencing technologies and personalized medicine are driving market expansion. North America is leading due to the rising focus on gut health among Americans. 

Last Updated : 27 November 2025 Category: Life Sciences Insight Code: 6042 Format: PDF / PPT / Excel

Content

TOC is not Available for this Report

FAQ's

Answer : The human microbiome market in 2026 is valued at USD 1.61 billion and is projected to climb to USD 18.27 billion by 2035, with a CAGR of 30.97% over the forecast period.

Answer : North America is currently leading the human microbiome market due to widespread use of advanced imaging technologies and a mature healthcare system.

Answer : Some key players include Finch Therapeutics, Vedanta Biosciences, Ferring Pharmaceuticals, MaaT Pharma, BiomX Inc., 4D pharma plc, and Synlogic.
Any Questions

Meet the Team

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology and healthcare services.

Learn more about Deepa Pandey

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar